ORINY Stock: Orion Oyj Stock Price, Analysis & Insights
Get live ORINY stock price $37.99, comprehensive Orion Oyj stock analysis, charts, news, and expert forecast. Real-time ORINY stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Orion Oyj is a Finnish pharmaceutical company specializing in the creation, production, and commercialization of medicines for both human and animal health, as well as the active components (APIs) essential for drug formulation. Its operations extend...
Company Information
- CEO
- Liisa Hurme
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 3943
Contact Information
- Website
- https://www.orion.fi
- Address
- Orionintie 1A
- Country
- FI
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 17.5)
✓ Lower volatility stock (Beta: 0.28) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Orion Oyj shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Orion Oyj
- ⚠Investors should consider how Orion Oyj fits within their overall portfolio allocation
Market Cap
21.38B
P/E Ratio (TTM)
17.51
Beta
0.28
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ORINY with peer companies:
- Price
- $13.25
- Market cap
- 23.74B
- Price
- $13.21
- Market cap
- 23.67B
- Price
- $5.93
- Market cap
- 13.36B
- Price
- $5.69
- Market cap
- 14.95B
- Price
- $64.00
- Market cap
- 33.70B
- Price
- $118.08
- Market cap
- 18.83B
- Price
- $11.69
- Market cap
- 18.64B
- Price
- $12.04
- Market cap
- 10.73B
- Price
- $4.40
- Market cap
- 18.22B
- Price
- $7.49
- Market cap
- 15.44B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.